Are you Dr. Deshpande?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7200 State Highway 161
Ste 220
Irving, TX 75039Phone+1 214-689-7806Fax+1 214-689-5970
Summary
- Dr. Devyani Deshpande, MD is an infectious disease specialist in Irving, Texas. She is currently licensed to practice medicine in Texas and New Jersey. She is affiliated with Medical City Las Colinas, Baylor Scott & White Medical Center-Irving, and Pine Creek Medical Center.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Infectious Disease, 2007 - 2009
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2004 - 2007
- N.K.P. Salve Institute Of Medical SciencesClass of 1999
Certifications & Licensure
- TX State Medical License 2009 - 2026
- NJ State Medical License 2005 - 2009
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsErtapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model.Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
International Journal of Antimicrobial Agents. 2024-09-01 - 2 citationsCeftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.Devyani Deshpande, Gesham Magombedze, Gunavanthi D Boorgula, Moti Chapagain, Shashikant Srivastava
The Journal of Infectious Diseases. 2024-08-16 - 5 citationsHollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.Tawanda Gumbo, Shashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, Alexander Berg
The Journal of Antimicrobial Chemotherapy. 2023-04-03